Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study. [electronic resource]
Producer: 20170613Description: 759-766 p. digitalISSN:- 1432-0843
- ATP Binding Cassette Transporter, Subfamily B -- genetics
- ATP Binding Cassette Transporter, Subfamily G, Member 2 -- genetics
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- pharmacokinetics
- Breast Neoplasms -- drug therapy
- Carcinoma, Hepatocellular -- drug therapy
- DNA -- genetics
- Drug Monitoring
- Female
- Genotype
- Humans
- Liver Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Proteins -- genetics
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- pharmacokinetics
- Polymorphism, Genetic -- genetics
- Polymorphism, Single Nucleotide -- genetics
- Protein Kinase Inhibitors -- pharmacokinetics
- Sorafenib
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.